Ubanan, Florencia .
HRN: 27-98-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/21/2025
10/27/2025
IV
4.5
Q6h
Uti
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes